Royal Bank of Canada Cuts Verastem (NASDAQ:VSTM) Price Target to $14.00
Verastem (NASDAQ:VSTM – Free Report) had its price objective cut by Royal Bank of Canada from $16.00 to $14.00 in a report released on Friday morning,Benzinga reports. They currently have an outperform rating on the biopharmaceutical company’s stock. A number of other research analysts have also recently commented on VSTM. HC Wainwright restated a “buy” […]
Verastem (NASDAQ:VSTM – Free Report) had its price objective cut by Royal Bank of Canada from $16.00 to $14.00 in a report released on Friday morning,Benzinga reports. They currently have an outperform rating on the biopharmaceutical company’s stock. A number of other research analysts have also recently commented on VSTM. HC Wainwright restated a “buy” […]
